Florida Surgeon General Joseph Ladapo has accused the Biden administration of going out of their way to disrupt the distribution of monoclonal antibody treatments.
The Sunshine State official stated on Tuesday that the Biden Administration was taking active steps to prevent the Regeneron and Eli Lilly treatments from getting to where they need to go.
According to FOX 13, the Biden administration recently paused shipments of Regeneron and Eli Lilly, following claims that these specific treatments are not effective against the omicron variant of the coronavirus.
“We are very concerned with the Biden administration and the HHS’ recent abrupt, sudden announcement that they are going to dramatically cut the number of monoclonal antibodies that are going to be sent to the state of Florida,” DeSantis said in a statement back in September.
Ladapo went on to echo the Biden Administration’s recent admission that no federal solution to the pandemic exists and that states should explore their own options.
“President Biden recently states that there is no federal solution to COVID-19… Therefore, I respectfully request that you allow states and healthcare practitioners to provide treatment options…” he wrote.
NEW: Florida Surgeon General says Biden Admin is "actively preventing" distribution of monoclonal antibodies by pausing shipments of Regeneron, in letter to HHS Sec.— Jay O'Brien (@jayobtv) December 28, 2021
Feds paused Regeneron bc it may not work against Omicron. FL says it can still be used in existing Delta cases. pic.twitter.com/9mmw5SsuZJ
© 2021 Bright Mountain Media, Inc. All rights reserved.
The content of this webpage may not be reproduced or used in any manner whatsoever without the express written consent of Bright Mountain Media, Inc. which may be contacted at firstname.lastname@example.org, ticker BMTM.